"Designing Growth Strategies is in our DNA"

U.S. Sexually Transmitted Disease Testing Market Size, Share & COVID-19 Impact Analysis, By Product Type (Instruments and Reagents & Kits), By Application (Chlamydia, Syphilis, Genital Herpes, Gonorrhea, Human Immunodeficiency Virus, Human Papillomavirus, and Others), By Setting (Laboratory Testing and Point-of-Care) By End User (Hospital & Clinics, Clinical Laboratories, and Others), and Country Forecast, 2023-2030

Last Updated: November 17, 2025 | Format: PDF | Report ID: FBI108002

 


To get information on various segments, share your queries with us

  ATTRIBUTE

  DETAILS

Study Period

2019-2030

Base Year

2022

Estimated Year

2023

Forecast Period

2023-2030

Historical Period

2019-2021

Growth Rate

CAGR of 8.7% from 2023 to 2030

Unit

Value (USD Billion)

Segmentation

By Product Type

  • Instruments
  • Reagents & Kits

By Application

  • Chlamydia
  • Syphilis
  • Genital Herpes
  • Gonorrhea
  • Human Immunodeficiency Virus
  • Human Papillomavirus (HPV)
  • Others

By Setting

  • Laboratory Testing
  • Point-of Care (POC)

By End User

  • Hospitals and Clinics
  • Diagnostic Centers
  • Others
  • 2019-2030
  • 2022
  • 2019-2021
  • 80
Download Free Sample

    man icon
    Mail icon
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann